AstraZeneca will likely re-test its COVID-19 vaccine, CEO says after admitting an error in the first trial that may have skewed results

AstraZeneca will likely re-test its COVID-19 vaccine, CEO says after admitting an error in the first trial that may have skewed results

Business Insider

Published

AstraZeneca announced Monday that its vaccine was up to 90% effective at preventing COVID-19. But an error in the trial may warrant a fresh test.

Full Article